Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.36 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL423281 | 0.82 | CYP2A6 (0.64) | CYP2A6LMNACYP1A2ALDH1A1MAPT | |
| SCHEMBL10947995 | 0.80 | LMNA (0.42) | CYP2A6LMNACYP1A2BCL2L1MCL1 | |
| SCHEMBL16479958 | 0.79 | CYP2A6 (0.43) | CYP2A6LMNACYP1A2ALDH1A1KDM4E | |
| SCHEMBL2092747 | 0.78 | CYP2A6 (0.71) | CYP2A6LMNAMCL1MAPTTP53 | |
| SCHEMBL5179107 | 0.78 | MAPT (0.54) | CYP2A6LMNABCL2L1MCL1ALDH1A1 | |
| SCHEMBL13950998 | 0.78 | CYP2A6 (0.46) | CYP2A6LMNAALDH1A1KDM4EHPGD | |
| SCHEMBL422469 | 0.78 | BCL2L1 (0.42) | CYP2A6LMNACYP1A2BCL2L1MCL1 | |
| SCHEMBL2095399 | 0.78 | CYP2A6 (0.46) | CYP2A6LMNAALDH1A1KDM4EMAPT | |
| SCHEMBL165522 | 0.78 | CYP2A6 (0.46) | CYP2A6LMNAALDH1A1HPGDHSD17B10 | |
| SCHEMBL2092120 | 0.78 | CYP2A6 (0.46) | CYP2A6ALDH1A1HSD17B10MAPTCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230046615-A1 | BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME | UNITED STATES DEPARTMENT OF ENERGY | 2023-02-16 | — | — | US | claimed |
| WO-2021127612-A1 | BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2021-06-24 | — | — | WO | claimed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| WO-2023238764-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | 住友化学株式会社 | 2023-12-14 | — | — | WO | disclosed |
| EP-2218716-A1 | METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| WO-2010050445-A1 | BICYCLIC COMPOUND | 武田薬品工業株式会社 (JP) | 2010-05-06 | — | — | WO | disclosed |
| US-7582658-B2 | Bicyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-7582658-B2 | Bicyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20090192154-A1 | SULTAM DERIVATIVES | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20090088406-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090088406-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1632483-B1 | HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | AVENTIS PHARMA INC (US) | 2008-10-29 | — | — | EP | disclosed |
| US-6410533-B1 | THERAPY FOR BACTERIA INFECTIONS | GENZYME CORPORATION | 2002-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046615-A1 | BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME | GHRHR, HCRTR1, CBR3 | CYP2A6 684/4885LMNA 1680/4885CYP1A2 206/4885 |
| US-20090088406-A1 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS | SLC6A2, TPH1, SLC6A3 | CYP2A6 565/4885LMNA 3720/4885CYP1A2 121/4885 |
| US-20090192154-A1 | SULTAM DERIVATIVES | SULT1A1, SULT2A1, ADAMTS1 | CYP2A6 1111/4885LMNA 2377/4885CYP1A2 1655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.